More NewsRead More
Synta Reports Inducement Grant to New Chief Executive Officer
September 04, 2014
Technical Analysis on Health Care Sector Equities -- Research on Ohr Pharma, Synta Pharma, Agenus, and PDL BioPharma
July 09, 2014
Patient Enrollments, Board Appointments, Acquisitions, and Technical Updates - Analyst Notes on Questcor, Synta, Clovis, Alnylam and Intrexon
July 08, 2014
Synta to Host Conference Call and Webcast of Second Quarter 2014 Financial Results on August 6, 2014
July 30, 2014
Synta Announces Advancement of Ganetespib into Phase 3 Extension of AML LI-1 Study for Patients with AML and High-Risk MDS
July 21, 2014
Synta Pharmaceuticals: New 52-Week Low Set Today (SNTA)
September 19, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here